Quantification of proprofol in small volumes of plasma using high-performance liquid chromatography with fluorescence detection. Therapeutic drug monitoring of one patient during and after infusion in the perioperative period of cardiac surgery

  • Carlos R. Da Silva Filho
  • , Roberto T.O. Kondo
  • , Andréia Z. Chignalia
  • , Karin V. López
  • , Valeria A. Pereira
  • , Maria J.C. Carmona
  • , José O.C. Auler
  • , Silvia R.C.J. Santos

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A liquid chromatographic method with fluorescence detection for determination of propofol in small volumes of plasma has been adapted to the conditions of the laboratory using a C18 column. Peaks were eluted at 21 min propofol and at 12 min thymol (internal standard) using a binary mobile phase at flow rate 0.8 mL/min. The method validated presents 0.05 mg/L sensitivity, 0.1-10 mg/L linearity, (r2 0.9977), systematic error of 8.2 and 7.0% (intra- and interday accuracy), intra- and interday precision (CV %: 8.4% and 8.8%). Recovery 93.9%, good stability and robustness were reported. The analytical method was validated by the quantification of propofol in arterial plasma (Cmax:3.3 mg/L Cmin: 0.2mg/L) of one patient received 1570 mg infusion of propofol in the perioperative period of surgery of myocardial revascularization. Depth of anaesthesia expressed as bispectral index (BIS) was 36 (32-40) in that period up to the 4th h, and an adequate hypnosis was obtained until the end of surgery.

Original languageEnglish (US)
Pages (from-to)748-754
Number of pages7
JournalLatin American Journal of Pharmacy
Volume26
Issue number5
StatePublished - Sep 2007
Externally publishedYes

Keywords

  • CLAE-F
  • Heart surgery
  • Propofol
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Quantification of proprofol in small volumes of plasma using high-performance liquid chromatography with fluorescence detection. Therapeutic drug monitoring of one patient during and after infusion in the perioperative period of cardiac surgery'. Together they form a unique fingerprint.

Cite this